IP Library Granted Patent US 8,133,473
Granted Patent B2
US 8,133,473 · App. 11/431,275 · Granted Mar 13, 2012

Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N

Assignee: Health Research, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,133,473
App. No.
11/431,275
Granted
Mar 13, 2012
Kind
B2
Abstract

A compound comprising a chemical combination of a photodynamic tetra-pyrrolic compound with a plurality of radionuclide element atoms such that the compound may be used to enhance MR imaging and also be used as a photodynamic compound for use in photodynamic therapy to treat hyperproliferative tissue. The preferred compounds have the structural formula: where R 1 , R 2 , R 2a R 3 , R 3a R 4 , R 5 , R 5a R 6 , R 7 , R 7a , and R 8 cumulatively contain at least two functional groups that will complex or combine with an MR imaging enhancing element or ion. The compound is intended to include such complexes and combinations and includes the use of such compounds for MR imaging and photodynamic therapy treatment of tumors and other hyperproliferative tissue.

Claims (4)

1. A composition comprising a chemical combination of a photodynamic tetra-pyrrolic compound having a chlorin or bacteriochlorin structure having four pendant groups attached to at least one pyrrole ring, said compound being provided with a plurality of radionuclide element atoms connected to a plurality of functional groups that will complex or combine with an MR imaging enhancing element wherein each such functional group contains at least one -DTPA moiety.

2. The composition of claim 1 wherein said compound is an HPPH aminophenyl DTPA conjugate.

3. The composition of claim 2 having an absorption wavelength at 660 nm.

4. The composition of claim 1 having an absorption frequency permitting in vivo tumor necrosis by absorption of light at its absorption frequency.

Assignments (1)
CONFIRMATORY LICENSE Recorded Nov 9, 2022
From: ROSWELL PARK CANCER INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 061901/0919 →
Continuity (4)
Division 10177129 · Jun 21, 2002
Continuation In Part 09739155 · Dec 18, 2000
Provisional Application 60171961 · Dec 23, 1999
Related Publication 20060204437A1 · Sep 14, 2006